Evidence map›Paper›PMID 42669598›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Charting Endocrine Progenitors Across Species and Organs.

Changying Jing, Michael Sterr, Özüm Sehnaz Caliskan, Lama Saber, Nicole Katarina Rogers, Samuel Ogden, Kei Kozawa, Christos Karampelias, Jessica Jaki, Aimée Bastidas-Ponce and 12 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Changying JingInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Michael SterrInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Özüm Sehnaz CaliskanGerman Center for Diabetes Research (DZD), Neuherberg, Germany.
Lama SaberInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Nicole Katarina RogersInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Samuel OgdenWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Kei KozawaInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Christos KarampeliasInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Jessica JakiInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Aimée Bastidas-PonceInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Falk Janos FarkasInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Oliver CzarneckiInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Osvaldo Rodrigues PereiraInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Perla CotaInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Valerie VandenbemptStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Diego BalboaStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Anika BöttcherInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Natalie KrahmerGerman Center for Diabetes Research (DZD), Neuherberg, Germany.
Mohammad LotfollahiWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Julie B SneddonDepartment of Cell and Tissue Biology, University of California, San Francisco, California, USA.
Heiko LickertInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.
Mostafa BakhtiInstitute of Diabetes and Regeneration Research, Helmholtz Munich, Neuherberg, Germany.ORCID https://orcid.org/0000-0002-2307-1122

Funding

Harnessing Novel Human Endocrine Progenitor Biology for Enhanced Generation of Beta Cells from Stem CellsR01DK144425 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SNEDDON, JULIE BETH · 2025 to 2025
$3.1M
A novel progenitor population in pancreatic endocrine cell developmentR01DK118421 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SNEDDON, JULIE BETH · 2019 to 2023
$2.1M
Alexander von Humboldt FoundationChina Scholarship Council 202208080154EFSD and Lilly European Diabetes Research ProgrammeGerman Center for Diabetes Research (DZD)Helmholtz Association-Initiative and Networking FundHelmholtz Portfolio Theme'Metabolic Dysfunction and Common DiseaseNIDDK NIH HHS R01 DK118421NIDDK NIH HHS R01 DK144425NIH/NIDDK R01DK118421NIH/NIDDK R01DK144425The Nora Eccles Treadwell Foundation
6 · The paper itself

Abstract

Hormone-producing cells in the pancreas and intestine regulate whole-body metabolism and are dysregulated in obesity and diabetes. A deeper understanding of endocrine lineage formation (endocrinogenesis) in these organs is essential to elucidate the healthy state and disease trajectories. Here, we performed cross-species (mouse and human) and cross-system (in vivo and in vitro) comparisons of pancreatic endocrine progenitors (EPs), complemented by cross-organ (pancreas and intestine) analyses, using single-cell transcriptomics and epigenomics, together with mouse bulk proteomics. We uncovered conserved and distinct gene regulatory networks (GRNs) and cell-cell communication patterns during lineage allocation across species, systems, and organs. Additionally, we identified diabetes-associated genes restricted to embryonic pancreatic EPs but largely absent in the adult pancreas, suggesting that dysregulation during development may predispose to diabetes. Furthermore, our multi-source EP profiling resolved the transcriptional programs underlying the aberrant, in vitro-enriched enterochromaffin cell formation during differentiation toward human islet cells, suggesting that these cells may not correspond to a naturally occurring cell type present in vivo development. Finally, we revealed conserved, dynamic shifts in the cell cycle and cytoskeletal organization, alongside divergent mRNA translation, during endocrinogenesis. Collectively, this multi-source EP profiling establishes a resource mapping the molecular landscape of endocrinogenesis across two major metabolic-endocrine organs.

Indexed as

cross‐speciesendocrinogenesisintestinepancreasprogenitors

Identifiers

PMID42669598
PMCPMC13526535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.